Construction method and application of a humanized mouse model of keloid
By constructing a humanized keloid mouse model, and utilizing CD27-CD70 axis activation and transgenic technology, the problem of the difficulty in observing the interaction between the immune system and keloids in existing models has been solved. This provides an extended experimental window and an effective platform for observing drug efficacy, making it suitable for keloid immunotherapy research.
CN119257071BActive Publication Date: 2026-03-03THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIV
2 Cites 0 Cited by
Patent Information
- Application Number
- CN202411404153.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-09
- Publication Date
- 2026-03-03
- Estimated Expiration
- 2044-10-09
Smart Images

Figure CN119257071B_ABST
Abstract
The application provides a construction method of a humanized keloid mouse model, comprising the following steps: BAC plasmid construction and preparation; superovulation of experimental mice and collection of zygotes; pronuclear microinjection of zygotes; post-injection embryo transplantation; genotype identification; breeding and genetic analysis; and verification of construction results of the humanized immune system by immunohistochemistry and immunofluorescence. In the application, peripheral blood mononuclear cells treated by sCD27 and skin around keloids (homologous cells and tissues) are transplanted into NSG-MHC-DKO immune-deficient mice with overexpression of CD70 genes, so that HLA rejection of different homologous immune cells and tissues can be avoided, the internal microenvironment of keloids and the interaction between the internal microenvironment and the immune system can be restored to the maximum extent, and the influence of immune factors on the occurrence and development of keloids can be realized in vitro. The application first discovers and verifies that the activation of the CD27-CD70 axis can promote the occurrence and development of keloids, and provides a suitable animal model for the research and development of anti-keloid drugs, especially immunotherapy.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Non-human animals comprising a humanized TTR locus with a beta-slip mutation and methods of use
US20200385760A1
KR20230015863A